Stimulus Package Funds Research Into Comparative Effectiveness

Funding to study the comparative effectiveness of healthcare treatments, including drugs, is part of the stimulus package Congress is considering now that lawmakers have recommended $1.1 billion to support such research. Comparative effectiveness studies that take the costs and effectiveness of drugs into account could affect sales of specific products.
Washington Drug Letter